Salvage therapy with pegylated liposomial doxorubicin-based regimen in relapsed/refractory multiple myeloma: comments to the article by Romano et al

MLA

Mariano Lucignano, et al. “Salvage Therapy with Pegylated Liposomial Doxorubicin-Based Regimen in Relapsed/Refractory Multiple Myeloma: Comments to the Article by Romano et Al.” European Journal of Haematology, vol. 96, no. 5, Nov. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4dd548522cfb13db78950f4a77b19b29&authtype=sso&custid=ns315887.

APA

Mariano Lucignano, Fabrizio Pane, Lucio Catalano, & Claudio Cerchione. (2015). Salvage therapy with pegylated liposomial doxorubicin-based regimen in relapsed/refractory multiple myeloma: comments to the article by Romano et al. European Journal of Haematology, 96(5).

Chicago

Mariano Lucignano, Fabrizio Pane, Lucio Catalano, and Claudio Cerchione. 2015. “Salvage Therapy with Pegylated Liposomial Doxorubicin-Based Regimen in Relapsed/Refractory Multiple Myeloma: Comments to the Article by Romano et Al.” European Journal of Haematology 96 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4dd548522cfb13db78950f4a77b19b29&authtype=sso&custid=ns315887.